{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:18:22Z","timestamp":1790252302530,"version":"4.1.0"},"reference-count":26,"publisher":"Federacion Colombiana de Obstetricia y Ginecologia","issue":"1","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Colomb. Obstet. Ginecol."],"abstract":"<jats:p>Objective: Describe the medium-term safety of the tension free vaginal tape obturator (TVT-O) procedure in terms of complications, cure and changes in quality of life (QoL) after the surgery. Materials and methods: Descriptive historical cohort that included women over 18 years of age who underwent TVT-O due to objectively proven stress urinary incontinence, urethral hypermobility or mixed urinary incontinence in which the stress component predominated, confirmed on urodynamic testing between July 2013-April 2017, in a reference hospital located in the city of Murcia Spain. Women with previous anti-incontinence surgery, concomitant vaginal surgery and planning pregnancy were excluded. Follow-up was determined for each patient based on the time elapsed between surgery and the time when the research protocol was applied. Complications were stratified according to the modified Clavien-Dindo classification; also we evaluated subjective cure rate, quality of life using the ICIQ-SF score, before and after surgery. Results: The mean age was 52.6 (SD\u00b1 10.5) years and 80.1% of patients were at least overweight. The incidence of complications at 12 months was: 8.3% (12\/144). We did not detect complications after this period in the followed patients at 24, 36 and 48 months. The subjective cure determined at 12, 24, 36 and 48 months was 62.5% (90\/144), 59.09% (55\/88), 50.81% (31\/61) and 50% (7\/14), respectively. There was a significant improvement in quality of life, as determined by the ICQ-SF mean score before and after surgery (13.76[6,34] vs 3.84[5.76]; p&lt;0.05). Conclusions: The TVT-O surgery is a safe therapy associated with a low complication incidence at 12 months, an acceptable subjective cure rate in stress urinary incontinence, and quality-of-life improvement. Classifications of complications related to the insertion of the prosthesis and of those inherent to surgery, such as urinary tract infection, are required.<\/jats:p>","DOI":"10.18597\/rcog.3613","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T17:25:17Z","timestamp":1617902717000},"page":"43-52","source":"Crossref","is-referenced-by-count":3,"title":["Medium-term safety outcomes in patients undergoing tension free vaginal tape obturator for stress urinary incontinence in Murcia, Spain. Historical cohort"],"prefix":"10.18597","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-2525","authenticated-orcid":false,"given":"Florencio Manuel","family":"Mar\u00edn-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-0187","authenticated-orcid":false,"given":"Juli\u00e1n","family":"O\u00f1ate-Celdr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0120-9178","authenticated-orcid":false,"given":"Olimpia","family":"Molina-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-5605","authenticated-orcid":false,"given":"Miriam","family":"Artes-Artes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-2806","authenticated-orcid":false,"given":"Emny Rochelle","family":"Bobadilla-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-2937","authenticated-orcid":false,"given":"V\u00edctor Javier","family":"Garc\u00eda-Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-7248","authenticated-orcid":false,"given":"Pablo Luis","family":"Guzm\u00e1n-Mart\u00ednez Valls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4580-5032","authenticated-orcid":false,"given":"Angel","family":"Andreu-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1801-0154","authenticated-orcid":false,"given":"Carlos","family":"S\u00e1nchez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5536-1407","authenticated-orcid":false,"given":"Dami\u00e1n","family":"Garc\u00eda-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-5806","authenticated-orcid":false,"given":"Mabel Coromoto","family":"Suarez-Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-168X","authenticated-orcid":false,"given":"Pedro","family":"Valdelvira-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7913","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"86933","doi-asserted-by":"crossref","unstructured":"D\u2019Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433\u201377. https:\/\/doi.org\/10.1002\/nau.23897","DOI":"10.1002\/nau.23897"},{"key":"86934","doi-asserted-by":"crossref","unstructured":"Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5\u201326. https:\/\/doi.org\/10.1007\/s00192-009-0976-9","DOI":"10.1007\/s00192-009-0976-9"},{"key":"86935","unstructured":"Milsom I, Altman D, Cartwright R, Lapitan MC, Nelson R, Sjostrom S, et al. Incontinence. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence 6th International Consultation on Incontinence, Tokyo, September 2017. 6th Ed. Tokyo: International Continence Society; 2017. p. 1\u2013142. Available from: https:\/\/www.ics.org\/publications\/ici_6\/Incontinence_6th_Edition_2017_eBook_v2.pdf"},{"key":"86936","doi-asserted-by":"crossref","unstructured":"Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I. Economic burden of urgency urinary incontinence in the United States: A systematic review. J Manag Care Pharm. 2014;20(2):130\u201340. https:\/\/doi.org\/10.18553\/jmcp.2014.20.2.130","DOI":"10.18553\/jmcp.2014.20.2.130"},{"key":"86937","doi-asserted-by":"crossref","unstructured":"Krhut J, G\u00e4rtner M, Mokris J, Horcicka L, Svabik K, Zachoval R, et al. Effect of severity of urinary incontinence on quality of life in women. Neurourol Urodyn. 2018;37(6):1925\u201330. https:\/\/doi.org\/10.1002\/nau.23568","DOI":"10.1002\/nau.23568"},{"key":"86938","unstructured":"Donovan J, Bosch R, Gotoh M, Jackson S, Naughton M, Radley S, et al. Symptom and quality of life assessment. Incontinence 3rd Int Consult Incontinence. 2005;519\u201384."},{"key":"86939","doi-asserted-by":"crossref","unstructured":"Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P. ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322\u201330. https:\/\/doi.org\/10.1002\/nau.20041","DOI":"10.1002\/nau.20041"},{"key":"86940","unstructured":"Busquets M, Serra R. Validaci\u00f3n del cuestionario international consultation on incontinence questionnaire short-form (ICIQ-SF) en una poblaci\u00f3n chilena usuaria del fondo nacional de salud (FONASA). Rev. Med. Chile. 2012;140(3):340\u2013346. https:\/\/doi.org\/10.4067\/S0034-8872012000300009"},{"key":"86941","doi-asserted-by":"crossref","unstructured":"Espu\u00f1a Pons M, Rebollo \u00c1lvarez P, Puig Clota M. Validaci\u00f3n de la versi\u00f3n espa\u00f1ola del International Consultation on Incontinence Questionnaire-Short Form. Un cuestionario para evaluar la incontinencia urinaria. Med Clin (Barc). 2004;122(8):288\u201392. https:\/\/doi.org\/10.1016\/S0025-7753(04)74212-8","DOI":"10.1016\/S0025-7753(04)74212-8"},{"key":"86942","doi-asserted-by":"crossref","unstructured":"Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10):CD005654. https:\/\/doi.org\/10.1002\/14651858.CD005654.pub4","DOI":"10.1002\/14651858.CD005654.pub4"},{"key":"86943","doi-asserted-by":"crossref","unstructured":"B\u00f8 K, Kvarstein B, Nygaard I. Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years. Obstet Gynecol. 2005;105(5 Pt 1):999\u20131005. https:\/\/doi.org\/10.1097\/01.AOG.0000157207.95680.6d","DOI":"10.1097\/01.AOG.0000157207.95680.6d"},{"key":"86944","doi-asserted-by":"crossref","unstructured":"Dmochowski RR, Blaivas JM, Gormley EA, Juma S, Karram MM, Lightner DJ, et al. Update of AUA Guideline on the Surgical Management of Female Stress Urinary Incontinence. J Urol. 2010;183(5):1906\u201314. https:\/\/doi.org\/10.1016\/j.juro.2010.02.2369","DOI":"10.1016\/j.juro.2010.02.2369"},{"key":"86945","doi-asserted-by":"crossref","unstructured":"Ford AA, Rogerson L, Cody JD, Aluko P, Ogah JA. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017; 7(7):CD006375. https:\/\/doi.org\/10.1002\/14651858.CD006375.pub4","DOI":"10.1002\/14651858.CD006375.pub4"},{"key":"86946","doi-asserted-by":"crossref","unstructured":"Brennand EA, Tang S, Birch C, Murphy M, Ross S, Robert M, et al. Five years after midurethral sling surgery for stress incontinence: obesity continues to have an impact on outcomes. Int Urogynecol J. 2017;28(4):621\u20138. https:\/\/doi.org\/10.1007\/s00192-016-3161-y","DOI":"10.1007\/s00192-016-3161-y"},{"key":"86947","doi-asserted-by":"crossref","unstructured":"Brennand EA, Tang S, Williamson T, Birch C, Murphy M, Robert M, et al. Twelve-month outcomes following midurethral sling procedures for stress incontinence: Impact of obesity. BJOG An Int J Obstet Gynaecol. 2015;122(12):1705\u201312. https:\/\/doi.org\/10.1111\/1471-0528.13132","DOI":"10.1111\/1471-0528.13132"},{"key":"86948","unstructured":"EAU Guidelines. Edn Present EAU Annu Congr Amsterdam. 2020;"},{"key":"86949","doi-asserted-by":"crossref","unstructured":"Gomes CM, Carvalho FL, Bellucci CHS, Hemerly TS, Baracat F, de Bessa Jr J, et al. Update on complications of synthetic suburethral slings. Int Braz J Urol. 2017;43(5):822\u201334. https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2016.0250","DOI":"10.1590\/s1677-5538.ibju.2016.0250"},{"key":"86950","doi-asserted-by":"crossref","unstructured":"Serati M, Braga A, Caccia G, Torella M, Ghezzi F, Salvatore S, et al. TVT-O for treatment of pure urodynamic stress urinary incontinence: Efficacy and adverse effects at 13-years follow-up. Neurourol Urodyn. 2020;39(5):1423\u2013 1429. https:\/\/doi.org\/10.1002\/nau.24358","DOI":"10.1002\/nau.24358"},{"key":"86951","doi-asserted-by":"crossref","unstructured":"Serati M, Braga A, Athanasiou S, Tommaselli GA, Caccia G, Torella M, et al. Tension-free Vaginal Tape\u2013Obturator for Treatment of Pure Urodynamic Stress Urinary Incontinence: Efficacy and Adverse Effects at 10-year Follow-up. Eur Urol. 2017;71(4):674\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.054","DOI":"10.1016\/j.eururo.2016.08.054"},{"key":"86952","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhu L, Xu T, Lang J. Retropubic tensionfree vaginal tape and inside-out transobturator tape: a long-term randomized trial. Int Urogynecol J. 2016;27(1):103\u201311. https:\/\/doi.org\/10.1007\/s00192-015-2798-2","DOI":"10.1007\/s00192-015-2798-2"},{"key":"86953","doi-asserted-by":"crossref","unstructured":"Zullo MA, Schiavi MC, Luffarelli P, Prata G, Di Pinto A, Oliva C. TVT-O vs. TVT-Abbrevo for stress urinary incontinence treatment in women: a randomized trial. Int Urogynecol J. 2020;31(4):703\u201310. https:\/\/doi.org\/10.1007\/s00192-019-04077-7","DOI":"10.1007\/s00192-019-04077-7"},{"key":"86954","doi-asserted-by":"crossref","unstructured":"Echavarr\u00eda-Restrepo LG, Trujillo-Gallego LF, Hurtado-Arango CM, G\u00f3mez-Londo\u00f1o M, Isaza-Sierra IC, Montoya-V\u00e9lez LP. Six months follow up of females treated with medium tension-free urethral slings for Urinary Stress Incontinence between 2007 and 2009 at the Pontificia Bolivariana teaching hospital in the city of Medellin, Colombia. Historical cohort. Rev Colomb Obstet Ginecol. 2011;62(3):237\u201343. https:\/\/doi.org\/10.18597\/rcog.210","DOI":"10.18597\/rcog.210"},{"key":"86955","doi-asserted-by":"crossref","unstructured":"Fernandez-gonzalez S, Martinez E, Lin X, Amat L. Contasure-needleless\u00ae compared with Monarc\u00ae for the treatment of stress urinary incontinence. Int Urogynecol J. 2016;28(7):1077\u201384. https:\/\/doi.org\/10.1007\/s00192-016-3231-1","DOI":"10.1007\/s00192-016-3231-1"},{"key":"86956","doi-asserted-by":"crossref","unstructured":"Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW, Deprest J, et al. An international urogynecological association (IUGA)\/international continence society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic flo. Neurourol Urodyn. 2011;30(1):2\u201312. https:\/\/doi.org\/10.1002\/nau.21036","DOI":"10.1002\/nau.21036"},{"key":"86957","doi-asserted-by":"crossref","unstructured":"Liapis A, Bakas P, Creatsas G. Efficacy of insideout transobturator vaginal tape (TVTO) at 4 years follow up. Eur J Obstet Gynecol Reprod Biol. 2010;148(2):199\u2013201. https:\/\/doi.org\/10.1016\/j.ejogrb.2009.11.004","DOI":"10.1016\/j.ejogrb.2009.11.004"},{"key":"86958","doi-asserted-by":"crossref","unstructured":"Masata J, Svabik K, Zvara K, Hubka P, Toman A, Martan A. Comparison of the efficacy of tension-free vaginal tape obturator (TVT-O) and single-incision tensionfree vaginal tape (AjustTM) in the treatment of female stress urinary incontinence: a 1-year follow-up randomized trial. Int Urogynecol J. 2016;27(10):1497\u2013505. https:\/\/doi.org\/10.1007\/s00192-016-3012-x","DOI":"10.1007\/s00192-016-3012-x"}],"container-title":["Revista Colombiana de Obstetricia y Ginecolog\u00eda"],"original-title":[],"link":[{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/download\/3613\/3689","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/download\/3613\/3689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T09:12:17Z","timestamp":1618564337000},"score":1,"resource":{"primary":{"URL":"https:\/\/revista.fecolsog.org\/index.php\/rcog\/article\/view\/3613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3,30]]}},"URL":"https:\/\/doi.org\/10.18597\/rcog.3613","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/1N5UR7","asserted-by":"object"}]},"ISSN":["2463-0225","0034-7434"],"issn-type":[{"value":"2463-0225","type":"electronic"},{"value":"0034-7434","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}